<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05113238</url>
  </required_header>
  <id_info>
    <org_study_id>003</org_study_id>
    <nct_id>NCT05113238</nct_id>
  </id_info>
  <brief_title>Oocyte Activation: Revised or Initial AGT Technique, Which is Better?! A Sibling-oocytes-split Design</brief_title>
  <official_title>Oocyte Activation: Revised or Initial Activated Gamete Treatment (AGT) Technique, Which is Better?! A Sibling-oocytes-split Design and Case Series of Chemical Pregnancies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Fertility Center, Egypt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hawaa Fertility Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Royal Fertility Center, Egypt</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted to compare two different Assisted Gamete treatment (AGT) with&#xD;
      oocyte-sibling-split design control group : AGT- initial protocol for activating oocytes by&#xD;
      culturing oocytes in calcium ionophore after injection for two rounds of 10 minutes at 37 C,&#xD;
      30 minutes after injection.&#xD;
&#xD;
      sample group : AGT-revised protocol oocytes will be injected by sperm previously cultured in&#xD;
      Ca ionophore and 0.4 pL of calcium ionophore then will be cultured in calcium ionophore after&#xD;
      injection for 10 minutes&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      investigators performed ICSI then with one of two activation protocols added : AGT-initial or&#xD;
      AGT-revised For the AGT initial protocol, Oocytes will be injected then will be incubated in&#xD;
      10 mM calcium ionophore (Sigma-Aldrich) for two rounds of 10 minutes at 37 C, 30 minutes&#xD;
      after ICSI injection, and then will be rinsed and transferred into culture medium.&#xD;
&#xD;
      For the AGT-revised protocol, ejaculated spermatozoa will be exposed to calcium ionophore in&#xD;
      a drop on the ICSI dish before injection. During the ICSI procedure, spermatozoa will be&#xD;
      aspirated individually from the drop containing calcium ionophore and immobilized in a&#xD;
      separate polyvinylpyrrolidone drop. Next, approximately 0.4 pL of calcium ionophore will be&#xD;
      aspirated into the micropipette and will be injected into the oocyte with the spermatozoa.&#xD;
      Post-ICSI oocytes will be then exposed to 50 mM calcium ionophore for 10 minutes at 37 C, and&#xD;
      then will be washed and placed in culture medium.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 25, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>single group of patients will be conducted into sibling-oocyte-split design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of top quality day 3 embryos</measure>
    <time_frame>3 days after ICSI procedure day</time_frame>
    <description>number of top quality embryos</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Top quality day 4 embryos</measure>
    <time_frame>4 days after ICSI procedure</time_frame>
    <description>number of top quality embryos</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Top quality day 5 embryos</measure>
    <time_frame>5 days after ICSI procedure</time_frame>
    <description>number of top quality embryos</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>chemical pregnancy rate</measure>
    <time_frame>15 days after embryo transfer procedure day</time_frame>
    <description>the number of positive pregnancy cases from overall cases</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Assisted Reproductive Technology</condition>
  <arm_group>
    <arm_group_label>AGT-Initial</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oocytes will be injected with spermatozoa and will be incubated in 10 mM calcium ionophore (Sigma-Aldrich) for two rounds of 10 minutes at 37 C, 30 minutes after ICSI injection, and then will be rinsed and transferred into culture medium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AGT-revised</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ejaculated spermatozoa will be exposed to calcium ionophore in a drop on the ICSI dish before injection. During the ICSI procedure, spermatozoa will be aspirated individually from the drop containing calcium ionophore and immobilized in a separate PVP drop. Next, approximately 0.4 pL of calcium ionophore will be aspirated into the micropipette and injected into the oocyte with the spermatozoa.&#xD;
Post-ICSI oocytes will be then exposed to 50 mM calcium ionophore for 10 minutes at 37C, and then will be washed and placed in culture medium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Assisted gamete activation</intervention_name>
    <description>compare two different assisted gamete activation protocols to improve ICSI outcome</description>
    <arm_group_label>AGT-Initial</arm_group_label>
    <arm_group_label>AGT-revised</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  couples presented with an extremely poor fertilization (&lt;10%)&#xD;
&#xD;
          -  couples with previous complete fertilization failure after undergoing ICSI cycles&#xD;
&#xD;
          -  At least 4 MII oocytes&#xD;
&#xD;
          -  Severe oligoasthinozoospermia&#xD;
&#xD;
          -  Teratozoospermia&#xD;
&#xD;
          -  testicular aspirated sperm&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &gt;40 years&#xD;
&#xD;
          -  BMI &gt;34&#xD;
&#xD;
          -  aspirated oocytes &lt; 4&#xD;
&#xD;
          -  Normozoospermia&#xD;
&#xD;
          -  subfertile patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sahar SA Eissa, PHD</last_name>
    <role>Study Director</role>
    <affiliation>research team leader</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Engy EA Abdallah, M.sc</last_name>
    <role>Study Chair</role>
    <affiliation>investigator &amp; researcher</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sahar SA Eissa, PHD</last_name>
    <phone>00201010397393</phone>
    <email>Saharafify@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmed AS saad, MD</last_name>
    <phone>00201221709989</phone>
    <email>drahmedsaad@live.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Fertility Center</name>
      <address>
        <city>Mansoura</city>
        <state>Daqahlya</state>
        <zip>35511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mohamed elzayat f center, Ph D</last_name>
      <phone>00201001529299</phone>
      <email>zayaregy@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 8, 2021</study_first_submitted>
  <study_first_submitted_qc>November 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2021</study_first_posted>
  <last_update_submitted>November 7, 2021</last_update_submitted>
  <last_update_submitted_qc>November 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Calcium ionophore</keyword>
  <keyword>gamete activation</keyword>
  <keyword>ICSI</keyword>
  <keyword>male factor</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>study protocol and outcome</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>two months</ipd_time_frame>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

